StockData
HeartSciences Inc. logo

HeartSciences Inc. (HSCS) stock

HSCSNasdaqFinance ServicesFiscal year ends April 30Also trades as HSCSW
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 3/30
$2.10+0.04 (+1.94%)

Close on Nov 18, 2026Market cap $10.08MP/E –Yield 0.00%

HeartSciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

HeartSciences's operating income for the twelve months ending Jul 31, 2026 was -$9.48M. For fiscal 2026 it was -$8.41M. The highest annual figure on record is -$4.71M in fiscal 2022.

Annual operating income

PeriodPeriod endValueChange
FY2026Apr 30, 2026-$8.41M–
FY2025Apr 30, 2025-$8.35M–
FY2024Apr 30, 2024-$6.31M–
FY2023Apr 30, 2023-$6.11M–
FY2022Apr 30, 2022-$4.71M–

Quarterly operating income

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026-$2.94M–
Q4 FY2026CQ1 2026Apr 30, 2026-$2.54M–
Q3 FY2026CQ4 2025Jan 31, 2026-$1.93M–
Q2 FY2026CQ3 2025Oct 31, 2025-$2.07M–
Q1 FY2026CQ2 2025Jul 31, 2025-$1.87M–
Q4 FY2025CQ1 2025Apr 30, 2025-$1.92M–
Q3 FY2025CQ4 2024Jan 31, 2025-$2.37M–
Q2 FY2025CQ3 2024Oct 31, 2024-$1.99M–
Q1 FY2025CQ2 2024Jul 31, 2024-$2.08M–
Q4 FY2024CQ1 2024Apr 30, 2024-$1.88M–
Q3 FY2024CQ4 2023Jan 31, 2024-$1.53M–
Q2 FY2024CQ3 2023Oct 31, 2023-$1.57M–
Q1 FY2024CQ2 2023Jul 31, 2023-$1.33M–
Q4 FY2023CQ1 2023Apr 30, 2023-$1.60M–
Q3 FY2023CQ4 2022Jan 31, 2023-$1.31M–
Q2 FY2023CQ3 2022Oct 31, 2022-$1.77M–
Q1 FY2023CQ2 2022Jul 31, 2022-$1.43M–
Q4 FY2022CQ1 2022Apr 30, 2022-$1.98M–
Q3 FY2022CQ4 2021Jan 31, 2022-$1.10M–
Q2 FY2022CQ3 2021Oct 31, 2021-$956.86K–
Q1 FY2022CQ2 2021Jul 31, 2021-$674.45K–

More HeartSciences figures

See a number that looks wrong?